Curiox Biosystems Co., Ltd (KOSDAQ:445680)

Market Cap	1.28T +209.2%
Revenue (ttm)	5.55B +41.6%
Net Income	-26.20B
EPS	-1,562.41
Shares Out	17.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	186,996
Open	82,100
Previous Close	88,900
Day's Range	75,400 - 84,900
52-Week Range	29,750 - 149,200
Beta	1.76
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 445680

Financial Performance

In 2025, Curiox Biosystems's revenue was 5.15 billion, an increase of 12.29% compared to the previous year's 4.59 billion. Losses were -27.18 billion, 236.0% more than in 2024.